Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

Medicine, Oncology, Pharmacology +15

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry et al. · New England Journal of Medicine · 2003 · 2.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

Toyoaki Murohara, Takayuki Asahara, David M. Silver et al. · Journal of Clinical Investigation · 1998 · 1.2K citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +12

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

Andreas Papapetropoulos, Guillermo García‐Cardeña, Joseph A. Madri et al. · Journal of Clinical Investigation · 1997 · 1.2K citations · Full text

Life Sciences, Cell Biology, Cell Proliferation +13